Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29820 | 0.87 | ALDH1A1 (0.41) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL5090654 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL27451943 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL17187059 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL27925652 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL27878548 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL17187057 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| Phosphoric Acid SCHEMBL1478991 | 0.84 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA7CYP3A4 | |
| SCHEMBL2066 | 0.84 | — | — | |
| Phosphoric Acid SCHEMBL28097386 | 0.82 | ALDH1A1 (0.38) | ALDH1A1CA1CA2CA7CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024005032-A1 | AZEPANDIONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | 株式会社ADEKA | 2024-01-04 | — | — | WO | disclosed |
| WO-2023190015-A1 | 1-ARYL TETRAHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE OR SALT THEREOF, PESTICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | 日本農薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023171665-A1 | PIPERIDINONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | 株式会社ADEKA | 2023-09-14 | — | — | WO | disclosed |
| WO-2023149473-A1 | MESOIONIC ARYL PYRIDAZINIUM DERIVATIVE OR SALT THEREOF, INSECTICIDE CONTAINING SAME, AND METHOD FOR USING SAME | 日本農薬株式会社 | 2023-08-10 | — | — | WO | disclosed |
| WO-2023127805-A1 | ARYL TETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, PESTICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | 日本農薬株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023127807-A1 | ARYL CYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | 株式会社ADEKA | 2023-07-06 | — | — | WO | disclosed |
| WO-2023127809-A1 | ARYL DIHYDROPYRAN DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | 株式会社ADEKA | 2023-07-06 | — | — | WO | disclosed |
| WO-2023127808-A1 | ARYLCYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | 株式会社ADEKA | 2023-07-06 | — | — | WO | disclosed |
| WO-2023127806-A1 | ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | 日本農薬株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023032747-A1 | RECYCLING TREATMENT DEVICE, WASHING-OUT DEVICE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE | 富士フイルム株式会社 | 2023-03-09 | — | — | WO | disclosed |
| WO-2021049596-A1 | AGRICULTURAL AND HORTICULTURAL INSECTICIDE OR ANIMAL ECTO- OR ENDO-PARASITE CONTROLLING AGENT WHICH CONTAINS IMIDAZOPYRIDAZINE COMPOUND HAVING SUBSTITUTED CYCLOPROPANE OXADIAZOLE GROUP OR SALTS THEREOF AS ACTIVE INGREDIENT, AND USAGE METHOD OF SAME | 日本農薬株式会社 | 2021-03-18 | — | — | WO | disclosed |
| WO-2021049595-A1 | AGRICULTURAL AND HORTICULTURAL PESTICIDE HAVING AS ACTIVE COMPONENT CONDENSED HETEROCYCLIC COMPOUND HAVING SUBSTITUTED CYCLOPROPANE OXADIAZOLE GROUP OR SALT THEREOF; ECTOPARASITE OR ENDOPARASITE CONTROL AGENT FOR ANIMALS; AND USE METHOD THEREOF | 日本農薬株式会社 | 2021-03-18 | — | — | WO | disclosed |
| WO-2021049597-A1 | INSECTICIDE AGENT FOR AGRICULTURAL OR HORTICULTURAL USE OR ANIMAL ECTOPARASITE OR ENDOPARASITE CONTROL AGENT EACH CONTAINING IMIDAZOPYRIDAZINE COMPOUND OR SALT THEREOF AS ACTIVE INGREDIENT, AND USE OF SAID INSECTICIDE AGENT AND SAID CONTROL AGENT | 日本農薬株式会社 | 2021-03-18 | — | — | WO | disclosed |
| WO-2020241606-A1 | CONDENSED HETEROCYCLIC COMPOUND OR SALT THEREOF COMPRISING NITROGEN ATOM IN CROSS-LINK, AND AGRICULTURAL PESTICIDE CONTAINING SAID COMPOUND AND METHOD FOR USING SAME | 日本農薬株式会社 | 2020-12-03 | — | — | WO | disclosed |
| EP-2711404-B1 | ULTRAVIOLET SHIELDING AGENT, METHOD FOR PRODUCING SAME, ULTRAVIOLET SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | SUMITOMO OSAKA CEMENT CO LTD (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9326920-B2 | Ultraviolet-shielding agent, method for producing the same, ultraviolet-shielding agent-containing dispersion liquid, and cosmetic preparation | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20140086966-A1 | ULTRAVIOLET-SHIELDING AGENT, METHOD FOR PRODUCING THE SAME, ULTRAVIOLET-SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2014-03-27 | — | — | US | disclosed |
| EP-2711404-A1 | ULTRAVIOLET SHIELDING AGENT, METHOD FOR PRODUCING SAME, ULTRAVIOLET SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | Sumitomo Osaka Cement Co., Ltd. (JP) | 2014-03-26 | — | — | EP | disclosed |
| EP-1926785-A1 | INK FOR RECORDING, AND INK CARTRIDGE, INK RECORDED MATTER, INKJET RECORDING APPARATUS AND INKJET RECORDING METHOD USING THE SAME | Ricoh Company, Ltd. (JP) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007023987-A1 | INK FOR RECORDING, AND INK CARTRIDGE, INK RECORDED MATTER, INKJET RECORDING APPARATUS AND INKJET RECORDING METHOD USING THE SAME | RICOH COMPANY, LTD. (JP) | 2007-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086966-A1 | ULTRAVIOLET-SHIELDING AGENT, METHOD FOR PRODUCING THE SAME, ULTRAVIOLET-SHIELDING AGENT-CONTAINING DISPERSION LIQUID, AND COSMETIC PREPARATION | ERCC4, ERCC1, XPA | ALDH1A1 641/4885CA1 4334/4885CA2 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.